Literature DB >> 22510866

Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients.

Sui-Foon Lo1, Shih-Ni Chang, Chih-Hsin Muo, Shih-Yin Chen, Fang-Yin Liao, Shu-Wei Dee, Pei-Chun Chen, Fung-Chang Sung.   

Abstract

Most studies associated diabetes mellitus (DM) with risk of cancer have focused on the Caucasian population and only a few types of cancer. Therefore, a large and comprehensive nationwide retrospective cohort study involving an Asian population was conducted to evaluate the risk of several major types of cancer among Type 2 DM patients. The study analyzed the nationwide population-based database from 1996 to 2009 released by the National Health Research Institute in Taiwan. Incidence and hazard ratios (HRs) were calculated for specific types of cancer. The overall risk of cancers was significantly greater in the DM cohort [N = 895,434; HR = 1.19, 95% confidence interval (CI) = 1.17-1.20], compared with non-DM controls (N = 895,434). Several organs in the digestive and urogenital systems showed increased risk of cancer. The three highest HRs were obtained from cancers of the liver (HR = 1.78, 95% CI = 1.73-1.84), pancreatic (HR = 1.52, 95% CI = 1.40-1.65), and uterus and corpus (HR = 1.38, 95% CI = 1.22-1.55). The risk increased with age, and men with DM aged ≥ 75 years exhibited the highest risk (HR = 7.76, 95% CI = 7.39-8.15). Subjects with DM in this population have a modest increased risk of cancer, similar to the Caucasian population for several specific types of cancer. Old men with DM have the highest risk of cancer. Careful screening for cancer in DM patients is important for early diagnosis and effective treatment.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22510866     DOI: 10.1002/ijc.27597

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  32 in total

1.  Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium.

Authors:  Yu Chen; Fen Wu; Eiko Saito; Yingsong Lin; Minkyo Song; Hung N Luu; Prakash C Gupta; Norie Sawada; Akiko Tamakoshi; Xiao-Ou Shu; Woon-Puay Koh; Yong-Bing Xiang; Yasutake Tomata; Kemmyo Sugiyama; Sue K Park; Keitaro Matsuo; Chisato Nagata; Yumi Sugawara; You-Lin Qiao; San-Lin You; Renwei Wang; Myung-Hee Shin; Wen-Harn Pan; Mangesh S Pednekar; Shoichiro Tsugane; Hui Cai; Jian-Min Yuan; Yu-Tang Gao; Ichiro Tsuji; Seiki Kanemura; Hidemi Ito; Keiko Wada; Yoon-Ok Ahn; Keun-Young Yoo; Habibul Ahsan; Kee Seng Chia; Paolo Boffetta; Wei Zheng; Manami Inoue; Daehee Kang; John D Potter
Journal:  Diabetologia       Date:  2017-03-07       Impact factor: 10.122

2.  Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.

Authors:  Chu-Wen Fang; Cheng-Hsi Liao; Shih-Chi Wu; Chih-Hsin Muo
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

3.  Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults.

Authors:  Peter T Campbell; Christina C Newton; Neal D Freedman; Jill Koshiol; Michael C Alavanja; Laura E Beane Freeman; Julie E Buring; Andrew T Chan; Dawn Q Chong; Mridul Datta; Mia M Gaudet; J Michael Gaziano; Edward L Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lindsey King; I-Min Lee; Martha S Linet; Julie R Palmer; Jessica L Petrick; Jenny N Poynter; Mark P Purdue; Kim Robien; Lynn Rosenberg; Vikrant V Sahasrabuddhe; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Victoria L Stevens; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Andrew G Renehan; Katherine A McGlynn
Journal:  Cancer Res       Date:  2016-10-15       Impact factor: 12.701

4.  The preoperative HbA1c level is an independent prognostic factor for the postoperative survival after resection of non-small cell lung cancer in elderly patients.

Authors:  Makoto Motoishi; Satoru Sawai; Tetsuo Hori; Naoki Yamashita
Journal:  Surg Today       Date:  2017-12-08       Impact factor: 2.549

5.  Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.

Authors:  San-Chi Chen; Chia-Jen Liu; Yu-Wen Hu; Chiu-Mei Yeh; Li-Yu Hu; Yen-Po Wang; Yi-Ping Hung; Cheng-Hwai Tzeng; Tzeon-Jye Chiou; Tzeng-Ji Chen; Chung-Jen Teng
Journal:  Gastric Cancer       Date:  2015-03-13       Impact factor: 7.370

6.  Metformin use and its effect on gastric cancer in patients with type 2 diabetes: A systematic review of observational studies.

Authors:  Peiwen Li; Cong Zhang; Peng Gao; Xiaowan Chen; Bin Ma; Dehao Yu; Yongxi Song; Zhenning Wang
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

Review 7.  Effects of sulfonylureas on tumor growth: a review of the literature.

Authors:  Giulia Pasello; Loredana Urso; Pierfranco Conte; Adolfo Favaretto
Journal:  Oncologist       Date:  2013-09-16

Review 8.  Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies.

Authors:  Caiyun Liao; Dongyu Zhang; Chemtai Mungo; D Andrew Tompkins; Amer M Zeidan
Journal:  Gynecol Oncol       Date:  2014-07-27       Impact factor: 5.482

Review 9.  Diabetes mellitus carries a risk of gastric cancer: a meta-analysis.

Authors:  Shouji Shimoyama
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 10.  Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.

Authors:  Hong Fang; Baodong Yao; Yujie Yan; Huilin Xu; Yinan Liu; Hongmei Tang; Jie Zhou; Lili Cao; Weijie Wang; Jinling Zhang; Liyun Zhao; Xi Chen; Fen Zhang; Yanping Zhao
Journal:  Diabetes Technol Ther       Date:  2013-11       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.